Among these candidate tumor suppressors, SNORD94, RNU2-1, SCARNA3, SNORD15B, and SCARNA2 appeared among the most promising for further validation, as their dysregulation was high and provided consistent results. The gene discussed is RNU2-1; the disease is neoplasm.